UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Cabaletta Bio Inc (CABA)

Cabaletta Bio Inc (CABA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2700 unch (unch) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3126 +0.0426 (+3.35%) 17:14 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.2300
Day High
1.3100
Open 1.3000
Previous Close 1.2700 1.2700
Volume 362,900 362,900
Avg Vol 949,415 949,415
Stochastic %K 75.83% 75.83%
Weighted Alpha -87.11 -87.11
5-Day Change +0.1700 (+15.45%) +0.1700 (+15.45%)
52-Week Range 0.9900 - 13.5000 0.9900 - 13.5000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,325
  • Shares Outstanding, K 50,743
  • Annual Sales, $ 0 K
  • Annual Income, $ -115,860 K
  • EBIT $ -125 M
  • EBITDA $ -121 M
  • 60-Month Beta 2.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.41

Options Overview Details

View History
  • Implied Volatility 511.81% ( +294.80%)
  • Historical Volatility 99.76%
  • IV Percentile 97%
  • IV Rank 56.35%
  • IV High 861.91% on 08/12/24
  • IV Low 59.81% on 07/31/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 206
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 9,333
  • Open Int (30-Day) 10,434

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.67
  • Number of Estimates 3
  • High Estimate -0.63
  • Low Estimate -0.70
  • Prior Year -0.51
  • Growth Rate Est. (year over year) -31.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9900 +28.28%
on 04/07/25
Period Open: 1.6600
1.6800 -24.40%
on 03/27/25
-0.3900 (-23.49%)
since 03/25/25
3-Month
0.9900 +28.28%
on 04/07/25
Period Open: 2.5000
2.9000 -56.21%
on 02/18/25
-1.2300 (-49.20%)
since 01/24/25
52-Week
0.9900 +28.28%
on 04/07/25
Period Open: 12.1800
13.5000 -90.59%
on 06/14/24
-10.9100 (-89.57%)
since 04/25/24

Most Recent Stories

More News
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

CABA : 1.2700 (unch)
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference

CABA : 1.2700 (unch)
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

CABA : 1.2700 (unch)
Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

CABA : 1.2700 (unch)
Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February

CABA : 1.2700 (unch)
Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference

CABA : 1.2700 (unch)
Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025

CABA : 1.2700 (unch)
Cabaletta Bio to Participate in Upcoming Investor Conferences in December

CABA : 1.2700 (unch)
2 Penny Stocks That Wall Street Predicts Will Soar 306% to 1,183% in 2025

Both penny stocks are a 'strong buy' on Wall Street.

CABA : 1.2700 (unch)
$SPX : 5,525.21 (+0.74%)
NTLA : 8.31 (+1.59%)
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024

CABA : 1.2700 (unch)

Business Summary

Cabaletta Bio Inc. is a clinical stage biotechnology company. It is focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's product pipeline consists of DSG3-CAART, DSG3/1-CAART, MuSK-CAART and FVIII-CAART which are...

See More

Key Turning Points

3rd Resistance Point 1.3900
2nd Resistance Point 1.3500
1st Resistance Point 1.3100
Last Price 1.2700
1st Support Level 1.2300
2nd Support Level 1.1900
3rd Support Level 1.1500

See More

52-Week High 13.5000
Fibonacci 61.8% 8.7212
Fibonacci 50% 7.2450
Fibonacci 38.2% 5.7688
Last Price 1.2700
52-Week Low 0.9900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective